APA

Kulke M. H., Ruszniewski P., Van Cutsem E., Lombard-Bohas C., Valle J. W., De Herder W. W., Pavel M., Degtyarev E., Brase J. C., Bubuteishvili-Pacaud L., Voi M., Salazar R., Borbath I., Fazio N., Smith D., Capdevila J., Riechelmann R. P. & Yao J. C. (112019). A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Kulke M H, Ruszniewski P, Van Cutsem E, Lombard-Bohas C, Valle J W, De Herder W W, Pavel M, Degtyarev E, Brase J C, Bubuteishvili-Pacaud L, Voi M, Salazar R, Borbath I, Fazio N, Smith D, Capdevila J, Riechelmann R P and Yao J C. 112019. A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Kulke M. H., Ruszniewski P., Van Cutsem E., Lombard-Bohas C., Valle J. W., De Herder W. W., Pavel M., Degtyarev E., Brase J. C., Bubuteishvili-Pacaud L., Voi M., Salazar R., Borbath I., Fazio N., Smith D., Capdevila J., Riechelmann R. P. and Yao J. C. (112019). A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Kulke M H, Ruszniewski P, Van Cutsem E, Lombard-Bohas C, Valle J W, De Herder W W, Pavel M, Degtyarev E, Brase J C, Bubuteishvili-Pacaud L, Voi M, Salazar R, Borbath I, Fazio N, Smith D, Capdevila J, Riechelmann R P and Yao J C. A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 112019.